HHS adolescent vaccination “hot buttons”
Executive Summary
The HHS National Vaccines Advisory Committee's adolescent working group identifies three "hot button" issues concerning adolescent immunization: school mandates for vaccination, informed consent and use of non-traditional venues for adolescent immunization. The group hopes to publish a draft "defining the problems" in the upcoming months and put out a report within a year. A number of adolescent vaccines have been approved recently, including Merck's human papillomavirus vaccine Gardasil and Sanofi-Pasteur's meningococcal conjugate vaccine Menactra (1"The Pink Sheet" Feb. 28, 2005, p. 28)...
You may also be interested in...
Menactra Launches For 11, 12, 15 Year Olds; First In Wave Of Teen Vaccines?
Sanofi-Pasteur will have approximately 5 mil. doses of Menactra (meningococcal quadrivalent conjugate vaccine) available for use in the U.S. during the first 12 months following launch
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.